Search hospitals > Pennsylvania > Philadelphia
Penn Presbyterian Medical Center
Claim this profilePhiladelphia, Pennsylvania 19104
Global Leader in Amyloidosis
Global Leader in Traumatic Brain Injury
Conducts research for Wounds and Injuries
Conducts research for Coronary Artery Disease
Conducts research for Non-Small Cell Lung Cancer
137 reported clinical trials
25 medical researchers
Summary
Penn Presbyterian Medical Center is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Amyloidosis, Traumatic Brain Injury, Wounds and Injuries, Coronary Artery Disease, Non-Small Cell Lung Cancer and other specialties. Penn Presbyterian Medical Center is involved with conducting 137 clinical trials across 212 conditions. There are 25 research doctors associated with this hospital, such as Sabine s Coppieters, MD, Wilson Szeto, MD, Howard Herrmann, MD, and Benjamin D'Souza.Area of expertise
1Amyloidosis
Global LeaderTTR
Stage I
Stage II
2Traumatic Brain Injury
Global LeaderTop PIs
Sabine s Coppieters, MDInvestigator site 2 - US00100872 years of reported clinical research
Studies Myasthenia Gravis
Studies Muscle Weakness
25 reported clinical trials
13 drugs studied
Wilson Szeto, MDThe Hospital of the University of Pennsylvania5 years of reported clinical research
Studies Aortic Aneurysm
Studies Thoracic Aortic Aneurysm
10 reported clinical trials
13 drugs studied
Howard Herrmann, MDUniversity of Pennsylvania5 years of reported clinical research
Studies Tricuspid Regurgitation
Studies Mitral Valve Regurgitation
8 reported clinical trials
11 drugs studied
Benjamin D'SouzaPenn Presbyterian Medical Center4 years of reported clinical research
Studies Atrial Fibrillation
Studies Heart Failure
7 reported clinical trials
8 drugs studied
Clinical Trials running at Penn Presbyterian Medical Center
Non-Small Cell Lung Cancer
Heart Failure
Lung Cancer
Amyloidosis
Traumatic Brain Injury
Prostate Cancer
Wounds and Injuries
Cardiac Arrest
Plantar Fasciitis
Cardiomyopathy
Crizotinib
for Non-Small Cell Lung Cancer
This study is evaluating whether a drug called crizotinib may help treat patients with non-small cell lung cancer.
Recruiting2 awards Phase 328 criteria
Liquid Biopsy NGS Prompt
for Lung Cancer
This study expands the application of an electronic health record (EHR) "nudge" used to prompt physicians' clinical practice to order molecular testing at the time of initial diagnosis for patients with specific types of advanced lung cancer. The primary goal is to have these test results available prior to starting treatment so that physicians can make molecularly-informed treatment decisions. The second goal is to better understand factors that contribute to whether or not the EHR-nudge implementation is successful.
Recruiting1 award N/A2 criteria
Genetic Testing
for Early-Stage Lung Cancer
This study is evaluating whether genetic testing may help determine the best treatment for patients with lung cancer.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Penn Presbyterian Medical Center?
Penn Presbyterian Medical Center is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Amyloidosis, Traumatic Brain Injury, Wounds and Injuries, Coronary Artery Disease, Non-Small Cell Lung Cancer and other specialties. Penn Presbyterian Medical Center is involved with conducting 137 clinical trials across 212 conditions. There are 25 research doctors associated with this hospital, such as Sabine s Coppieters, MD, Wilson Szeto, MD, Howard Herrmann, MD, and Benjamin D'Souza.